Descripción

Immunohistochemical staining for CD31 (endothelial marker) quantifies microvessel density in tissue samples, confirming quercetin's anti-angiogenic effect at the tissue level.

Figure 8

Micrograph

Source Paper

Inhibition of Angiogenic Factor Productions by Quercetin In Vitro and In Vivo.

Medicines (Basel, Switzerland) (2021)

PMID: 34065895

DOI: 10.3390/medicines8050022

Cite This Figure

![Figure 8: Immunohistochemical staining for CD31 (endothelial marker) quantifies microvessel density in tissue samples, confirming quercetin's anti-angiogenic effect at the tissue level.]()

> Source: Takayuki Okumo et al. "Inhibition of Angiogenic Factor Productions by Quercetin In Vitro and In Vivo.." *Medicines (Basel, Switzerland)*, 2021. PMID: [34065895](https://pubmed.ncbi.nlm.nih.gov/34065895/)

<figure>
  <img src="" alt="Immunohistochemical staining for CD31 (endothelial marker) quantifies microvessel density in tissue samples, confirming quercetin's anti-angiogenic effect at the tissue level." />
  <figcaption>Figure 8. Immunohistochemical staining for CD31 (endothelial marker) quantifies microvessel density in tissue samples, confirming quercetin's anti-angiogenic effect at the tissue level.<br>  Source: Takayuki Okumo et al. "Inhibition of Angiogenic Factor Productions by Quercetin In Vitro and In Vivo.." <em>Medicines (Basel, Switzerland)</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34065895/">34065895</a></figcaption>
</figure>

Evidencia relacionada

Quercetin para Allergic Rhinitis

Calificación C · 5 estudios